Furthermore, celastrol improved MCD diet-induced steatohepatitis and hepatic fibrosis, which increased BSH activity decreased ileal FXR pathway, and alleviated bile acids level in the liver (Supplementary Figs. 18, 19). The gene discussed is NR1H4; the disease is Hepatic fibrosis.